Latest Astellas Pharma Stories
NORTHBROOK, Ill., April 27, 2015 /PRNewswire/ -- Astellas announced today that CRESEMBA® (isavuconazonium sulfate), the prodrug for isavuconazole, is now available in the United States
Exclusive Collaboration Includes Option for Astellas to Acquire Potenza TOKYO and CAMBRIDGE, Mass., April 21, 2015 /PRNewswire/ -- Astellas Pharma Inc.
NORTHBROOK, Ill., April 15, 2015 /PRNewswire/ -- Astellas today announced that Jennifer Saputo has been appointed to the role of associate director, Employee Communications, as part of the Company's
TOKYO, April 6, 2015 /PRNewswire/ -- Astellas ("Astellas,") (Tokyo: 4503) today announced that Dr. Shontelle Dodson has been named vice president, Medical Excellence, Medical Affairs.
TOKYO and HOUSTON, April 3, 2015 /PRNewswire/ -- Astellas Pharma Inc.
Nominations now being accepted for the award, which will be presented in December at a special event in Aspen, Colorado NORTHBROOK, Ill.
Astellas sponsors health education and awareness program at the nation's oldest African-American athletic conference event CHICAGO, IL (PRWEB) February 23,
Astellas is Exclusive Health Sponsor of the 'Ticket2Health' Initiative Promoting a Game Plan for Better Health and Wellness NORTHBROOK, Ill., Feb.
NORTHBROOK, Ill., Feb.
- Emitting flashes of light; glittering.